Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
A selective PIKfyve inhibitor blocks PtdIns(3,5)P 2 production and disrupts endomembrane transport and retroviral budding
2008
Trans , trans , trans -[PtIV(N3)2(OH)2(py)(NH3)]: A Light-Activated Antitumor Platinum Complex That Kills Human Cancer Cells by an Apoptosis-Independent Mechanism
2012
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma
2015
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2011
Untangling the ErbB signalling network
2001 Standout
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
HER-2/neu Protein: A Target for Antigen-Specific Immunotherapy of Human Cancer
1997
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
2020
Consumption and its discontents: addiction, identity and the problems of freedom
2004
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent
2014 StandoutNobel
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Mammalian phosphoinositide kinases and phosphatases
2009 StandoutNobel
The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function
2012
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Identification and Characterization of the Binding Sites of P-Glycoprotein for Multidrug Resistance-Related Drugs and Modulators
2004
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Use of a microbubble agent to increase the effects of high intensity focused ultrasound on liver tissue
2005
Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA
2012
The ground state of embryonic stem cell self-renewal
2008 StandoutNature
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Selective activation of anticancer prodrugs by monoclonal antibody–enzyme conjugates
2001
Hepatocellular carcinoma
2021 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
2012
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models
2015
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Targeting multidrug resistance in cancer
2006 Standout
The Role of c-erbB-2/HER2/neu in Breast Cancer Progression and Metastasis
2001
Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
2012
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Saturation in qualitative research: exploring its conceptualization and operationalization
2017 Standout
Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises
2008
Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
2012
Microtubules as a target for anticancer drugs
2004 Standout
Pharmacokinetic and Pharmacodynamic Implications of P‐glycoprotein Modulation
2001
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
2017 Standout
Endosome maturation
2011 Standout
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients
2017
Kinetic parameters for small-molecule drug delivery by covalent cell surface targeting
2001 StandoutNobel
Development of Multidrug-Resistance Convertors: Sense or Nonsense?
2000
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
2013
A strategy for the isolation of catalytic activities from repertoires of enzymes displayed on phage 1 1Edited by J. Karn
1999 StandoutNobel
Conditional ablation of Ikkb inhibits melanoma tumor development in mice
2010
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
Acute Myeloid Leukemia
2015 Standout
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates
2002 Standout
Brands as symbolic resources for the construction of identity
1998 Standout
Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma.
2000
The Megaphone Effect: Taste and Audience in Fashion Blogging
2012 Standout
Brand Community
2001 Standout
The Autonomy Paradox: The Implications of Mobile Email Devices for Knowledge Professionals
2013 Standout
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Spatializing commodity chains
1999
In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
2001
Consumer Culture Theory (CCT): Twenty Years of Research
2005 Standout
Grounded theory, ethnography and phenomenology
2005 Standout
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
The governance of global value chains
2005 Standout
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis
2001 StandoutNobel
Users of the world, unite! The challenges and opportunities of Social Media
2009 Standout
Vigilante Marketing and Consumer-Created Communications
2007
Sustained Tumor Regression of Human Colorectal Cancer Xenografts Using a Multifunctional Mannosylated Fusion Protein in Antibody-Directed Enzyme Prodrug Therapy
2005
The selectivity of protein kinase inhibitors: a further update
2007 Standout
Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
2000
How Brand Community Practices Create Value
2009 Standout
We Are What We Post? Self-Presentation in Personal Web Space
2003
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Time-dependent whole-body fluorescence tomography of probe bio-distributions in mice
2005
Antibody-directed enzyme prodrug therapy (ADEPT): a review
1997
Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs.
1995
Combining TRAIL with PI3 Kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling
2013
Multiple event activation of a generic prodrug trigger by antibody catalysis
1999 StandoutNobel
The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond
2014
The Price is Unfair! A Conceptual Framework of Price Fairness Perceptions
2004 Standout
Outraged Consumers: Getting Even at the Expense of Getting a Good Deal
2003
Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
2014
Works of Sue Eccles being referenced
Pharmacological properties of the PI3 kinase (PI3K) inhibitors PI-540 and PI-620
2008
Reframing Ikea: commodity signs, consumer creativity and the social/self dialectic
1996
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185.
1994
In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance
1999
Treatment of implanted liver tumors with focused ultrasound
1998
Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
2012
Revenge, existential choice, and addictive consumption
1996
Mechanism of action of the Aurora kinase inhibitor CCT129202 and in vivo quantification of biological activity
2007
414A Pharmacological properties and in vitro and in vivo antitumour activity of the potent and selective PI3 kinase inhibitor PI103
2004
The lived experiences of women as addictive consumers
2002
Towards a theory of shopping: a holistic framework
2002